Newron Pharmaceuticals S.p.A. Logo

Newron Pharmaceuticals S.p.A.

NWRN | SW

Overview

Corporate Details

ISIN(s):
IT0004147952
LEI:
8156002F8C11F80A9740
Country:
Italy
Address:
VIA MEUCCI, 3, 20091 BRESSO
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Newron Pharmaceuticals S.p.A. is a biopharmaceutical company focused on the development of innovative therapies for diseases of the central and peripheral nervous system.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-12 07:00
Regulatory News Service
Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide…
English 17.2 KB
2025-08-12 02:00
Regulatory News Service
EQS-News: Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with…
English 15.8 KB
2025-08-12 02:00
Regulatory News Service
EQS-News: Newron beginnt Rekrutierung für zulassungsrelevantes Phase-III-Entwic…
German 18.5 KB
2025-08-11 07:00
Environmental & Social Information
Newron notes the publication of new preclinical research suggesting evenamide a…
English 19.4 KB
2025-08-11 02:00
Regulatory News Service
EQS-News: Newron notes the publication of new preclinical research suggesting e…
English 17.8 KB
2025-08-11 02:00
Regulatory News Service
EQS-News: Newron verweist auf die Veröffentlichung neuer präklinischer Forschun…
German 20.9 KB
2025-05-12 07:00
Regulatory News Service
Newron gibt Genehmigung fur zulassungsrelevantes Phase-III-Entwicklungsprogram…
German 12.6 KB
2025-05-12 02:00
Regulatory News Service
EQS-Adhoc: Newron gibt Genehmigung für zulassungsrelevantes Phase-III-Entwickl…
German 11.3 KB
2025-05-12 02:00
Legal Proceedings Report
EQS-News: Newron announces approval for pivotal Phase III ENIGMA-TRS program w…
English 19.4 KB
2025-05-12 02:00
Regulatory News Service
EQS-News: Newron gibt Genehmigung für zulassungsrelevantes Phase-III-Entwicklu…
German 22.8 KB
2025-04-24 16:22
Director's Dealing
Newron Pharmaceuticals S.p.A.: Tuula Martin, buy
English 6.3 KB
2025-04-23 11:30
Post-Annual General Meeting Information
Generalversammlung 2025 von Newron Pharmaceuticals: Chris Martin zum neuen Verw…
German 7.5 KB
2025-04-07 17:17
Director's Dealing
Newron Pharmaceuticals S.p.A.: Stefan Weber, buy
English 5.9 KB
2025-04-01 07:00
Earnings Release
Newron gibt Geschaftsergebnisse 2024 und Ausblick 2025 bekannt
German 12.5 KB
2025-03-24 17:45
Board/Management Information
Newron schlagt renommierten Biopharma-Firmengrunder und -Unternehmer Dr. Chris …
German 8.9 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC